» Authors » Joachim Hoppmann

Joachim Hoppmann

Explore the profile of Joachim Hoppmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 66
Followers 0
Related Specialties
Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Baumer W, Hoppmann J, Rundfeldt C, Kietzmann M
Inflamm Allergy Drug Targets . 2007 Mar; 6(1):17-26. PMID: 17352685
The phosphodiesterase (PDE) 4 is the predominant cyclic AMP degrading enzyme in a variety of inflammatory cells including eosinophils, neutrophils, macrophages, T cells and monocytes. In addition, this enzyme is...
2.
Hoppmann J, Baumer W, Galetzka C, Hofgen N, Kietzmann M, Rundfeldt C
J Pharm Pharmacol . 2005 Dec; 57(12):1609-17. PMID: 16354405
The selective phosphodiesterase 4 (PDE4) inhibitor AWD 12-281 is structurally optimized for topical administration. It has potent effects in models of lung inflammation if administered as a dry powder inhalation....
3.
Baumer W, Gorr G, Hoppmann J, Ehinger A, Rundfeldt C, Kietzmann M
J Pharm Pharmacol . 2003 Sep; 55(8):1107-14. PMID: 12956900
AWD 12-281 (N-(3,5-dichloro-4-pyridinyl)-2-[1-(4-fluorobenzyl)-5-hydroxy-1H-indol-3-yl]-2-oxoacetamide), a phosphodiesterase 4 inhibitor, which is optimized for topical administration, was tested in a model of allergic dermatitis in mice. To obtain an allergic dermatitis, BALB/c mice...
4.
Baumer W, Gorr G, Hoppmann J, Ehinger A, Ehinger B, Kietzmann M
Eur J Pharmacol . 2002 Jul; 446(1-3):195-200. PMID: 12098602
The inhibitors of the phosphodiesterase 4, SB 207499 (cilomilast, c-4-cyano-4-(3-cyclopentyloxy-4-methoxy-phenyl)-r-L-cyclohexane carboxylic acid) and AWD 12-281 (N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide) were tested in a model of allergic dermatitis in mice. To obtain...